People: Ablynx NV (ABLX.BR)

ABLX.BR on Brussels Stock Exchange

9.06EUR
19 Dec 2014
Price Change (% chg)

€-0.12 (-1.31%)
Prev Close
€9.18
Open
€9.20
Day's High
€9.25
Day's Low
€9.04
Volume
45,459
Avg. Vol
76,117
52-wk High
€10.18
52-wk Low
€6.89

Search Stocks

Moukheibir, Catherine 

Brief Biography

Ms. Catherine Moukheibir serves as Independent Member of the Board of Directors of Ablynx NV. She has been in C-level positions in several European biotech companies after an initial career in strategy consulting and investment banking in Boston and London. Her particular experience lies in aligning corporate and financial strategy appropriate to various stages of a biotech’s development, on the continuum from venture capital funding to public market or mergers and acquisitions. She is currently a Non-Executive Board Member of Creabilis and a Member of the three-person Executive Committee at Innate Pharma where she is responsible for financial and corporate strategy. She holds a Masters degree from Yale University and a Masters of Business Administration degree from Yale University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks